Methods and systems for analysis of epigenetic biomarker proxies
The integration of multi-omic assays and methylation analysis in a clinical context addresses the inefficiencies of current multi-omic profiling, enabling cost-effective and accurate disease detection through multi-omic biomarkers and epigenetic proxies, supporting precision medicine.
WO2026128639A1PCT designated stage Publication Date: 2026-06-18TRU DIAGNOSTICS INC
Patent Information
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- TRU DIAGNOSTICS INC
- Filing Date
- 2025-12-10
- Publication Date
- 2026-06-18
Smart Images
Figure US2025059059_18062026_PF_FP_ABST
Abstract
Described are methods and systems for determining or identifying a disease in a subject. The methods may include obtaining a biological sample of the subject. The methods may also include performing a first assay on the biological sample or derivatives thereof to measure one or more multiomic biomarkers. The methods may also include extracting nucleic acid molecules from the biological sample of the subject. The methods may also include performing a second assay on the extracted nucleic acid molecules or derivatives thereof to generate an assay result. The methods may also include determining the presence or the absence of the disease in the subject. The systems described may be configured to execute the methods described.
Need to check novelty before this filing date? Find Prior Art